Investing.com - Artelo Biosciences (NASDAQ:ARTL) reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that was in line with expectations.
Artelo Biosciences announced earnings per share of $-0.8200 on revenue of $0.00. Analysts polled by Investing.com anticipated EPS of $-0.9133 on revenue of $0.00.
Artelo Biosciences shares are down 41.36% from the beginning of the year, still down 82.79% from its 52 week high of $16.50 set on November 8, 2021.
Artelo Biosciences shares gained 3.65% in intra-day trade following the report.
Artelo Biosciences follows other major Healthcare sector earnings this month
Artelo Biosciences's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar